Cholesterol promotes autoimmune pathology through T follicular helper cells

Affiliations

¹ Department of Medicine, Beth Isarael Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. wli12@bidmc.harvard.edu.
² Department of Medicine, Beth Isarael Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Comment

Wei Li et al. Cell Mol Immunol. 2025 Aug.

. 2025 Aug;22(8):951-953.

doi: 10.1038/s41423-025-01319-1. Epub 2025 Jul 10.

¹ Department of Medicine, Beth Isarael Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. wli12@bidmc.harvard.edu.
² Department of Medicine, Beth Isarael Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Erratum in

Correction: Cholesterol promotes autoimmune pathology through T follicular helper cells.
Li W, Tsokos GC. Li W, et al. Cell Mol Immunol. 2025 Nov;22(11):1519. doi: 10.1038/s41423-025-01350-2. Cell Mol Immunol. 2025. PMID: 41044208 Free PMC article. No abstract available.

No abstract available

Competing interests: The authors declare no competing interests.

FXR inhibition functions as a checkpoint blockade of the pathogenic Tfh cell response in lupus.
Wang X, Ye L, Liu S, Zheng Y, Zhu L, Huang W, Song J, Shao J, Wu F, Zhang C, Li X, Zeng S, Xiao Y, Chen X, Fu S, Ye L, Zhou J, Cao Y. Wang X, et al. Cell Mol Immunol. 2025 Aug;22(8):889-900. doi: 10.1038/s41423-025-01309-3. Epub 2025 Jun 25. Cell Mol Immunol. 2025. PMID: 40562871

1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110–21. 10.1056/NEJMra1100359. - PubMed
1. Tsokos GC. The immunology of systemic lupus erythematosus. Nat Immunol. 2024;25:1332–43. 10.1038/s41590-024-01898-7. - PubMed
1. Morel L. Immunometabolism in systemic lupus erythematosus. Nat Rev Rheumatol. 2017;13:280–90. 10.1038/nrrheum.2017.43. - PubMed
1. Sharabi A, Tsokos GC. T-cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy. Nat Rev Rheumatol. 2020;16:100–12. 10.1038/s41584-019-0356-x. - PubMed
1. Wang X, Ye L, Liu S, Zheng Y, Zhu L, Huang W, et al. FXR inhibition functions as a checkpoint blockade of the pathogenic Tfh cell response in lupus. Cell Mol Immunol. 2025;22:889–900. - PMC - PubMed